Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Claudio, Bazzi"'
Autor:
Claudio Bazzi
Publikováno v:
International Journal of Clinical Studies and Medical Case Reports. 29
Autor:
NS. Claudio Bazzi
Publikováno v:
International Journal of Clinical Case Reports and Reviews. 11:01-05
In FSGS with Nephrotic Syndrome (NS) 23 patients (61%) of 38 with functional outcome are in remission with very long follow up (from 60 to 331 months) after treatment with Steroids alone or in combination with Cyclophosphamide. It would be interestin
Autor:
Claudio Bazzi
Publikováno v:
International Journal of Clinical Studies and Medical Case Reports. 27
Autor:
Claudio Bazzi
Publikováno v:
International Journal of Clinical Studies and Medical Case Reports. 27
Autor:
Claudio Bazzi
Publikováno v:
International Journal of Clinical Case Reports and Reviews. 11:01-07
Background: In glomerulonephritis (GN) with nephrotic syndrome (NS), proteinuric and novel molecular biomarkers do not achieve 100% accuracy in predicting outcome and treatment responsiveness. Aim of study: To verify whether the combined excretion of
Autor:
Claudio Bazzi, Teresa M Seccia, Pietro Napodano, Cristina Campi, Brasilina Caroccia, Leda Cattarin, Lorenzo A Calò
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 6, p 1656 (2020)
The key role of arterial hypertension in chonic kidney disease (CKD) progression is widely recognized, but its contribution to tubulointerstitial damage (TID) in glomerulonephritis (GN) remains uncertain. Hence, the objective of this study is to clar
Externí odkaz:
https://doaj.org/article/e217f5b51f1c456189040963c8890e77
Autor:
Claudio Bazzi
Publikováno v:
International Journal of Clinical Case Reports and Reviews. 8:01-06
Background: In IgAN with cellular crescents (CIgAN) urinary excretion of α2-macroglobulin (α2m/C, MW 720 kDa) may be a marker of podocytes damage induced by crescents. The purpose of the study was the evaluation of the clinical significance of α2m
Publikováno v:
Nephrology & Renal Therapy. 7:1-8
In Glomerulonephritis (GN) with Nephrotic Syndrome (NS) proteinuric and molecular biomarkers don’t reach 100% of outcome prediction and treatment responsiveness.
Autor:
Claudio Bazzi, Elena Tagliabue, Sara Raimondi, Virginia Rizza, Daniela Casellato, Masaomi Nangaku
Publikováno v:
International Journal of Nephrology, Vol 2015 (2015)
Metabolic acidosis correction in advanced renal failure slows renal function decline attributed to tubulointerstitial damage (TID) reduction. No study evaluated if spontaneous baseline high urinary pH (UpH) is renoprotective in patients with normal r
Externí odkaz:
https://doaj.org/article/d8cdc1b25b5946d5b43225c83f0d5e4f
Autor:
Brasilina Caroccia, Pietro Napodano, Lorenzo A. Calò, Cristina Campi, Leda Cattarin, Claudio Bazzi, Teresa Maria Seccia
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1656, p 1656 (2020)
Journal of Clinical Medicine
Volume 9
Issue 6
Journal of Clinical Medicine
Volume 9
Issue 6
The key role of arterial hypertension in chonic kidney disease (CKD) progression is widely recognized, but its contribution to tubulointerstitial damage (TID) in glomerulonephritis (GN) remains uncertain. Hence, the objective of this study is to clar